Some considerations on manufacturing — there’s a variety of product quality steps necessary to release batches of medicine. The FDA mandates this as part of GMP regulations. These steps help ensure things like: * How do I know that every vial has the same concentration of insulin each time? That is to say 1 unit from a vial today and 1 unit from another vial is going to have the same dosing. * How do I know the insul…
Where are you getting this from? This goal of this isn't to have every diabetic brewing insulin in their garage so they evade the IP police in a distrubuted fasion. The goal is to create open IP needed for creation, purification and quality control that will allow labs around the world to create insulin in keeping with local regulations.